Olaris, founded in 2014 by Liz O’Day, is using “biomarkers of response” to determine the best possible course of drugs to treat patients most effectively.
This Biotech Startup Is Out To Change How Drugs Are Prescribed
Olaris, founded in 2014 by Liz O’Day, is using “biomarkers of response” to determine the best possible course of drugs to treat patients most effectively.